{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:42:11Z","timestamp":1787776931707,"version":"build-2784847793"},"reference-count":32,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,15]]},"abstract":"<jats:p>The von Hippel-Lindau (VHL) tumor suppressor gene targets hypoxia-inducible transcription factors (HIFs) for proteasomal degradation. Erythrocytosis due to inappropriate production of erythropoietin (EPO), one of the HIF target genes, is a classic albeit rare finding in patients with renal cancer. We report the clinical to molecular analysis in a patient in whom a thrombotic myocardial infarction was the first manifestation of a clear cell renal carcinoma associated with an elevated serum EPO level (109 U\/L) and erythrocytosis (hemoglobin 200 g\/L [20 g\/dL]). The tumor strongly expressed EPO messenger RNA and the 2 regulatory subunits HIF-1\u03b1 and HIF-2\u03b1. Sequence analysis of tumor tissue identified a point mutation of the VHL gene (nucleotide 701 T&amp;gt;C) with a predicted amino acid exchange (Leu163Pro). This structural change, although located at distance to the HIF-binding region, was found to inhibit binding of HIF-1\u03b1 to VHL, thus leading to accumulation of HIF, which drives EPO production.<\/jats:p>","DOI":"10.1182\/blood.v99.10.3562","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:48:18Z","timestamp":1033508898000},"page":"3562-3565","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma"],"prefix":"10.1182","volume":"99","author":[{"given":"Michael S.","family":"Wiesener","sequence":"first","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchior","family":"Seyfarth","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Warnecke","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Steffen","family":"Ju\u0308rgensen","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rosenberger","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil V.","family":"Morgan","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn R.","family":"Maher","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Frei","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Medical Intensive Care, Charite\u0301, Humboldt-University, Berlin, Germany; Medical Clinic and German Heart Center of the Technical University Munich, Germany; and Department of Paediatrics, Section of Medical and Molecular Genetics, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218170416400_B1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM199105093241907","article-title":"Erythropoietin.","volume":"324","author":"Erslev","year":"1991","journal-title":"N Engl J Med."},{"key":"2020021218170416400_B2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.1996.76.3.839","article-title":"Oxygen sensing and molecular adaptation to hypoxia.","volume":"76","author":"Bunn","year":"1996","journal-title":"Physiol Rev."},{"key":"2020021218170416400_B3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Rev Cell Dev Biol."},{"key":"2020021218170416400_B4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature."},{"key":"2020021218170416400_B5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease.","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine."},{"key":"2020021218170416400_B6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0959-437X(00)00152-0","article-title":"The von Hippel-Lindau tumor suppressor protein.","volume":"11","author":"Ivan","year":"2001","journal-title":"Curr Opin Genet Dev."},{"key":"2020021218170416400_B7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.","volume":"292","author":"Ivan","year":"2001","journal-title":"Science."},{"key":"2020021218170416400_B8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science."},{"key":"2020021218170416400_B9","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J."},{"key":"2020021218170416400_B10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2169\/internalmedicine.38.991","article-title":"Gene expression of erythropoietin in renal cell carcinoma.","volume":"38","author":"Noguchi","year":"1999","journal-title":"Intern Med."},{"key":"2020021218170416400_B11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V75.3.577.577","article-title":"Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia.","volume":"75","author":"Da Silva","year":"1990","journal-title":"Blood."},{"key":"2020021218170416400_B12","first-page":"1415","article-title":"New human renal carcinoma cell line established from a patient with erythrocytosis.","volume":"43","author":"Sytkowski","year":"1983","journal-title":"Cancer Res."},{"key":"2020021218170416400_B13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V63.4.828.828","article-title":"Erythropoietin production in a primary culture of human renal carcinoma cells maintained in nude mice.","volume":"63","author":"Hagiwara","year":"1984","journal-title":"Blood."},{"key":"2020021218170416400_B14","first-page":"5215","article-title":"Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1\u03b1 in clear cell renal carcinomas.","volume":"61","author":"Wiesener","year":"2001","journal-title":"Cancer Res."},{"key":"2020021218170416400_B15","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V92.7.2260","article-title":"Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1\u03b1.","volume":"92","author":"Wiesener","year":"1998","journal-title":"Blood."},{"key":"2020021218170416400_B16","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases.","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"2020021218170416400_B17","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/sj.onc.1203938","article-title":"Up-regulation of hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.","volume":"19","author":"Krieg","year":"2000","journal-title":"Oncogene."},{"key":"2020021218170416400_B18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/nar\/26.1.256","article-title":"Software and database for the analysis of mutations in the VHL gene.","volume":"26","author":"Beroud","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"2020021218170416400_B19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science."},{"key":"2020021218170416400_B20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI8161","article-title":"Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.","volume":"104","author":"Ohh","year":"1999","journal-title":"J Clin Invest."},{"key":"2020021218170416400_B21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1\u03b1 regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.","volume":"10","author":"Clifford","year":"2001","journal-title":"Hum Mol Genet."},{"key":"2020021218170416400_B22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(01)90135-0","article-title":"Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders.","volume":"38","author":"Prchal","year":"2001","journal-title":"Semin Hematol."},{"key":"2020021218170416400_B23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma.","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med."},{"key":"2020021218170416400_B24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1097-0142(197007)26:1<191::AID-CNCR2820260124>3.0.CO;2-S","article-title":"Erythropoietin levels in patients with renal tumors or cysts.","volume":"26","author":"Murphy","year":"1970","journal-title":"Cancer."},{"key":"2020021218170416400_B25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00252823","article-title":"Prevalence of paraneoplastic erythropoietin production by renal cell carcinomas.","volume":"72","author":"Gross","year":"1994","journal-title":"Clin Invest."},{"key":"2020021218170416400_B26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000474825","article-title":"Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.","volume":"21","author":"Ljungberg","year":"1992","journal-title":"Eur Urol."},{"key":"2020021218170416400_B27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/41.3.8429197","article-title":"Colocalization of erythropoietin mRNA and ecto-5\u2032-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin.","volume":"41","author":"Bachmann","year":"1993","journal-title":"J Histochem Cytochem."},{"key":"2020021218170416400_B28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ki.1993.362","article-title":"Identification of the renal erythropoietin-producing cells using transgenic mice.","volume":"44","author":"Maxwell","year":"1993","journal-title":"Kidney Int."},{"key":"2020021218170416400_B29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19850501)55:9<1918::AID-CNCR2820550915>3.0.CO;2-9","article-title":"Production of erythropoietin-like activity by human renal and hepatic carcinomas in cell culture.","volume":"55","author":"Okabe","year":"1985","journal-title":"Cancer."},{"key":"2020021218170416400_B30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood.V54.1.245.245","article-title":"Erythropoietin levels in the course of a patient with erythropoietin-producing renal cell carcinoma and transplantation of this tumor in nude mice.","volume":"54","author":"Toyama","year":"1979","journal-title":"Blood."},{"key":"2020021218170416400_B31","first-page":"3430","article-title":"Erythropoietin-induced polycythemia in athymic mice following transplantation of a human renal carcinoma cell line.","volume":"48","author":"Shouval","year":"1988","journal-title":"Cancer Res."},{"key":"2020021218170416400_B32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","article-title":"Erythropoietin stimulates proliferation of human renal carcinoma cells.","volume":"58","author":"Westenfelder","year":"2000","journal-title":"Kidney Int."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/10\/3562\/1684557\/h81002003562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/10\/3562\/1684557\/h81002003562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:25:45Z","timestamp":1581553545000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/10\/3562\/106947\/Paraneoplastic-erythrocytosis-associated-with-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,15]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.10.3562","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,15]]}}}